Pharma News

Self-folding polymers containing gadolinium forming nanosized complexes could be the key to enhanced magnetic resonance imaging and next-generation drug delivery, as demonstrated by scientists at Tokyo Tech. Thanks to their small size, low toxicity, and good tumor accumulation and penetration, these complexes represent a leap forward in contrast agents for cancer diagnosis, as well as neutron capture radiotherapy.

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Fabhalta® (iptacopan) as the first oral monotherapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH). Fabhalta is a Factor B inhibitor that acts proximally in the alternative complement pathway of the immune system, providing comprehensive control of red blood cell (RBC) destruction within and outside the blood vessels (intra- and extravascular hemolysis [IVH and EVH]).

Sildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability and delay clinical worsening.

A new study from Mass Eye and Ear investigators shows that individuals who report tinnitus, which present as a ringing in the ears in more than one out of ten adults worldwide, are experiencing auditory nerve loss that is not picked up by conventional hearing tests.

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) has delivered a University of Adelaide-developed vaccine and elicited an effective immune response to Zika virus in mice.

Merck, a leading science and technology company, has announced the winners of Merck Young Scientist Award 2023, season-3 to recognise young scientists in India.

The Association of Advanced pharmacy practitioners (AAPP) strongly urges the government of India to change certain drafted rules of National pharmacy commission Bill. The recommendations of AAPP mainly focused on number of members in council, minimum qualification to registered as pharmacist and national level entrance examination to enter in pharmacy education.

The Pharmacy Council of India (PCI) will launch a revamped – DIGI-PHARMed application on December 1 with four integrated services having an objective to regulate the Pharmacy education in the country by enrollment/ registration of Pharmacy institutions/ Pharmacist/ Pharmacy student/ Pharmacist jobseeker across India.

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Ivabradine Tablets, 5 mg and 7.5 mg (USRLD: Corlanor® Tablets, 5 mg and 7.5 mg).